Journals in Life sciences

131-140 of 456 results in All results

Current Opinion in Physiology

ISSN: 2468-8673
5 Year impact factor: 2.5
Impact factor: 2.5

What Current Opinions in Physiology publishes - COPHYS distinctly publishes invited short, annotated reviews in a Special Issue format. These short reviews are of recent (2-5 years) developments in the topic, as well as pointing out select individual papers of particular significance Each Special Issue focuses on a specific area of physiological research that has a broad appeal and falls within the aims and scope of the journal. Special Issues provide an opportunity to review a particular theme, examine previously unaddressed aspects, propose, and develop new approaches, exchange perspectives and encourage new lines of research.Expertise & the Editorial Process - Editors and the Editorial Board bring the depth and breadth of their experience and expertise to our journal. Each special issue's topic is facilitated and approved by the Co-Editors in Chief. The Editors in Chief work in tandem with the Editorial Board to select the most appropriate Guest Editors who are known experts in any given special issue's topic. The Guest Editors are responsible for creating an author invite list, which is then reviewed and augmented via Editorial Board evaluation prior to the Guest Editor inviting the contributing authors. The Guest Editors can also opt for the open call on the webpage along with the author's list.Once the papers for any of our curated short review special issues are received by COPHYS, the editorial staff determines their suitability for review. Submissions are checked that they are according to journal guidelines before being sent for external peer review by the Guest Editor via the submission platform. Each submission must be reviewed by no fewer than two independent experts who assess the quality, originality, and novelty of the work.COPHYS Guest Editors are not permitted to handle the review of their own contributions to ensure a thorough and fair review of their manuscripts. Guest Editors are not privy to the referees' names or affiliations for any submission under consideration where a Guest Editor is a contributor. Guest Editors must declare a potential conflict of interest for any submission under consideration and inform the journal Editors in Chief who then determine the appropriate course of action. For additional information about the role and responsibility of Guest Editors, please review the Elsevier Guest Editor Guide. As articles of the issue are accepted, the Editors in Chief perform a final evaluation of the articles before publication.Discoverability - Articles receive high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Current Opinion and Research - Current Opinion in Physiology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy of editorial excellence, high impact, and global reach to ensure they are a widely read resource that is integral to scientists' workflow.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Current Opinion in Plant Biology

ISSN: 1369-5266
5 Year impact factor: 8.6
Impact factor: 8.3

Excellence paves the way With Current Opinion in Plant BiologyPlease note that review articles in Current Opinion in Plant Biology are by invitation only.Current Opinion in Plant Biology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating high quality reproducible research. It is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy - of editorial excellence, high-impact, and global reach - to ensure they are a widely read resource that is integral to scientists' workflow.Expertise: Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Discoverability: Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Plant Biology, we help the reader by providing in a systematic manner:1. The views of experts on current advances in plant biology in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Division of the subject into sections: The subject of plant biology is divided into themed sections which are reviewed regularly to keep them relevant. Presently they are: Growth and development - Genome studies and molecular genetics (+ Plant biotechnology every other year) - Cell biology and cell signaling - Epigenetics and gene regulation - Physiology and metabolism - Biotic interactionsSelection of topics to be reviewed: Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.Reviews: Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview: Section Editors write an Introduction at the beginning of the section to give an overview about the topic and introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing - General Statement: The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.

Current Opinion in Structural Biology

ISSN: 0959-440X
5 Year impact factor: 6
Impact factor: 6.1

Current Opinion in Structural Biology (COSB) aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In COSB, we help the reader by providing in a systematic manner:1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.The journal is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the primary research, open access journal, Current Research in Structural Biology . CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely-read resource that is integral to scientists' workflows.COSB will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Division of the subject into sectionsThe subject of Structural Biology is divided into thirteen themed sections, each of which is reviewed once a year. Folding, Binding, and Protein Design AI Methodologies in Structural Biology Theory and Simulation/Computational Methods Macromolecular Assemblies New Concepts in Drug Discovery Single Molecule and Macromolecular Dynamics 3D Genome and Subcellular Organization Membranes and Membrane Proteins Cryo-EM Biophysical Methods Protein-Nucleic Acid Interactions Catalysis and Regulation Single Cell and Cell-Cell Interactions Selection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.Review articles in COSB are by invitation only. The journal does not accept manuscripts other from those invited by section editors, appointed by Editors-in-Chief.Review ArticlesThe Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In the Current Opinion journals, we help the reader by providing in a systematic manner: (1) The views of experts on current advances in the field in a clear and readable form. (2) Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. The aim of the manuscript is to review recent articles, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, you are encouraged to give your subjective opinion of the topics discussed, although you should not concentrate unduly on your own research. Your review should be approximately 2000 words (not including references or reference notes), with approximately 50 references and, as such, the review is intended to be a concise view of the field as it is at the moment, rather than a comprehensive overview. Our audience ranges from student to professor, so articles must be accessible to a wide readership. Please avoid jargon, but do not oversimplify: be accurate and precise throughout. Occasionally, unpublished data can be referred to, but only when essential and should never be used to substantiate any significant point. Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments. This successful format has made COSB one of the most highly regarded review journals in the field.Please see further information under writing and formatting – additional information.

Current Opinion in Toxicology

ISSN: 2468-2020
Impact factor: 6.1

Affiliated with the International Union of ToxicologyCurrent Opinion in Toxicology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise, and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Toxicology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Toxicology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Current Opinion in Toxicology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Toxicology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Division of the subject into sections: For this purpose, the scope of Toxicology is divided into six selected, high impact themed sections, each of which is reviewed once a year:Mechanistic ToxicologyMetabolic ToxicologyRisk assessment in ToxicologyGenomic ToxicologySystems ToxicologyTranslational ToxicologyExpertise: Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant. Comprehensiveness: There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry. Impact: In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores. Discoverability: Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast, global audience.Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors in Chief of the journal. They divide their sections into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authors on each topic that they have selected and arrange for the peer review process. The papers are reviewed by 2 independent reviewers.Reviews Authors write short review articles (approx. 2500 words), in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the 3-5 years.All content published in Current Opinion in Toxicology is by invitation only.Editorial Overview Section Editors write a short overview at the beginning of the section, to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General Statement The Editors and the Publisher of this journal believe that there are fundamental principles underlying scholarly and professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper, are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures, if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict.For more information, please refer to: https://www.elsevier.com/conflictsofinterestThe CiteScore for this journal is 9.1 and it ranks 8th in Scopus Toxicology category.

Current Opinion in Virology

ISSN: 1879-6257
5 Year impact factor: 5.5
Impact factor: 5.7

Please note that review articles in Current Opinion in Virology are by invitation only.Current Opinion in Virology (COVIRO) is a systematic review journal that aims to provide specialists with a unique and educational platform to keep up to date with the expanding volume of information published in the field of virology. It publishes 6 issues per year covering the following 11 sections, each of which is reviewed once a year: Emerging viruses: interspecies transmission; Viral immunology; Viral pathogenesis; Preventive and therapeutic vaccines; Antiviral strategies; Virus structure and expression; Animal models for viral diseases; Engineering for viral resistance; Viruses and cancer; Virus vector interactions. There is also a section that changes every year to reflect hot topics in the field.Current Opinion in Virology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Virological Science and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to https://www.elsevier.com/conflictsofinterestBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.Reviews Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Currents in Pharmacy Teaching and Learning

ISSN: 1877-1297
5 Year impact factor: 1.7
Impact factor: 1.3

Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricular outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/perceptions within pharmacy education

Cytokine

ISSN: 1043-4666
5 Year impact factor: 3.5
Impact factor: 3.7

An Official journal of the International Cytokine & Interferon Society (ICIS)Cytokine will publish studies that report on the molecular biology, signal transduction, genetics, biochemistry, immunology, genome-wide association, pathobiology, diagnostic, clinical, and therapeutic applications of all known and emerging cytokines, cytotoxins, interferons, chemokines, adipokines, matrikines, hematopoietic factors, and growth factors. Studies reporting all signaling molecules from the pathogens and host-endogenous sources, metabolic products/adducts that mediate inflammation and immunity, either influence and/or operate under this broad class of "biological response modifiers" as they relate to host defenses and immune responses will be considered for publication.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Cytokine & Growth Factor Reviews

ISSN: 1359-6101
5 Year impact factor: 10.2
Impact factor: 9.3

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Cytotherapy

ISSN: 1465-3249
5 Year impact factor: 4.3
Impact factor: 3.7

The official journal of the International Society for Cell & Gene Therapy (ISCT®)Cytotherapy, the official journal of the International Society of Cell and Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials on emerging trends and potential controversies in the field, and Review articles summarizing important areas of cell and gene therapy research that are topical and/or challenge existing paradigms in the field.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeuticsDesign of novel therapeutic approaches employing cell/EV/gene products.Mode of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.Identification of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.Role of stem/stromal cells and/or EVs in disease pathophysiology.Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.Important advances in cell/EV/gene-based product manufacturing and validationGlobal/regional regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.Cytotherapy does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the field.Basic/translational studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiologyStudies describing signaling pathways implicated in cancer

DNA Repair

ISSN: 1568-7864
5 Year impact factor: 3.7
Impact factor: 3

DNA Repair (DNAREP) is a journal focusing on DNA repair and cellular responses to DNA damage. DNA Repair publishes articles on genetic, cellular, biochemical, structural and molecular aspects of DNA repair. The journal welcomes articles describing databases, methods and new technologies supporting research on DNA repair and responses to DNA damage. Letters to the Editor, hot topics and classics in DNA repair, historical reflections, book reviews and meeting reports will also be considered for publication.The journal publishes topics directly pertaining to DNA damage and repair, which include:ApoptosisBiological responses to genomic insultCell cycle regulationCell fate decisionsEpigenetics and chromatinGenomics/bioinformaticsHuman diseases: aging, cancer, and neurological dysfunctionImmune responsesMutagenesis & signature mutationsStructural biology and computational modeling

Related subjects

Agricultural and biological sciences

Drug discovery

Immunology

Microbiology and virology

Neuroscience

Pharmaceutical sciences

Pharmacology

Toxicology

Life sciences

Physical sciences & Engineering

Social sciences & Humanities

Health